CORZIDE (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the CORZIDE drug offered from Pfizer Laboratories Div Pfizer Inc. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
NON-PROPRIETARY NAME: | nadolol and bendroflumethiazide |
SUBSTANCE NAME: | NADOLOL; BENDROFLUMETHIAZIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1983-05-25 |
END MARKETING DATE: | 0000-00-00 |
CORZIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | CORZIDE from Pfizer Laboratories Div Pfizer Inc |
LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40; 5(mg/1; mg/1) |
START MARKETING DATE: | 1983-05-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60793-283_6a0ac6f2-a99a-4985-92ea-9fd16b37c15c |
PRODUCT NDC: | 60793-283 |
APPLICATION NUMBER: | NDA018647 |
Other NADOLOL; BENDROFLUMETHIAZIDE Pharmaceutical Manufacturers / Labelers: